Today: 10 June 2026
Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next
15 January 2026
1 min read

Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next

New York, Jan 15, 2026, 16:57 EST — After-hours

  • Strategy dropped 4.7% Thursday, dragged down by a late sell-off in bitcoin and retreat in crypto-related stocks
  • A U.S. Senate committee delayed discussion on a crypto market-structure bill following objections from Coinbase’s CEO to the draft
  • Strategy scheduled for Feb. 5, following the release of fourth-quarter results after the close

Strategy Inc (MSTR) shares ended Thursday down 4.7%, settling at $170.91. The stock saw a brief early rally that fizzled out by the closing bell, and it showed minimal movement in after-hours trading.

This is significant since the stock has behaved less like a typical software play and more like a high-beta stand-in for bitcoin, which dropped roughly 2% late Thursday following a brief rally.

The U.S. Senate Banking Committee delayed its scheduled markup—a key session to debate and vote on amendments—of a bill aimed at establishing a regulatory framework for crypto markets. Coinbase CEO Brian Armstrong weighed in on X, saying the exchange cannot back the draft in its current form. “We’d rather have no bill than a bad bill,” he stated. Reuters

Strategy, headquartered in Tysons Corner, Virginia, plans to release its fourth-quarter 2025 results after U.S. markets close on Thursday, Feb. 5. The company will also host a live video webinar at 5 p.m. Eastern to review the financials.

Shares tied to crypto took a hit, with Coinbase sliding 6.5% and Robinhood down 7.8%.

Strategy’s internal records indicate it owns 687,410 bitcoin, bought for roughly $51.8 billion, averaging $75,353 per coin.

The firm, once known as MicroStrategy, also offers enterprise analytics software. Yet it’s the bitcoin holdings — and the financing behind them — that usually drive the stock’s daily moves.

The risk is straightforward: Washington could prolong the standoff, while bitcoin’s price might swing sharply. If the token falls further, it could put Strategy shares under pressure right as they approach their next earnings report.

Traders will keep an eye on bitcoin Friday to see if it holds steady following the bill’s delay, while lawmakers weigh in on a potential new schedule for the stalled markup.

The next key event arrives Feb. 5, when Strategy releases its earnings after the market closes. Investors will get an updated look at its bitcoin approach and the underlying balance-sheet figures.

Stock Market Today

  • Dynatrace (DT) Shares Show 33% Discount Based on Cash Flow Valuation
    June 10, 2026, 5:31 PM EDT. Dynatrace (DT) share price fell 9.3% last week, trading around $40.77, down 3.7% year to date. A discounted cash flow (DCF) analysis values the stock at $61.13, suggesting a 33.3% undervaluation. The model projects free cash flow rising to $1.04 billion by 2031. Despite mixed sentiment in software and cloud sectors, this cash flow based approach indicates potential value. Dynatrace scored 2 out of 6 on Simply Wall St's valuation framework, reflecting investor caution amid growth and revenue concerns. This highlights reassessment of pricing for cloud software stocks amid shifting market perspectives on growth sustainability.

Latest articles

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Freshworks Stock Steady at $9.39 Ahead of AI Test

Freshworks Stock Steady at $9.39 Ahead of AI Test

10 June 2026
Freshworks traded flat near $9.39 on volume more than double average as investors weighed its AI-driven restructuring and Freshservice focus; with Q2 restructuring costs looming, the stock faces a key test to prove AI shifts can boost margins without hurting growth, while net dollar retention dipped to 106% and large-customer ARR rose 29%.
ERock Falls in NYSE Debut, AI Power Firm Starts Trading Below IPO Price

ERock Falls in NYSE Debut, AI Power Firm Starts Trading Below IPO Price

10 June 2026
ERock plunged 12.37% below its $21.50 IPO price on debut as investors questioned whether its $1.28 billion AI data-center power-system backlog—$1.1 billion tied to AI projects—will convert to revenue, despite surging demand and a major Meta contract; risks flagged include customer cancellations and execution challenges, with the company posting a $17.2 million quarterly loss.
Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Previous Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

XRP price slips today as Senate delays crypto bill, Ripple rolls out $150 million LMAX deal
Next Story

XRP price slips today as Senate delays crypto bill, Ripple rolls out $150 million LMAX deal

Go toTop